Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 26; no. 35; pp. 5820 - 5823
Main Authors Narimatsu, Hiroto, Hori, Akiko, Matsumura, Tomoko, Kodama, Yuko, Takita, Morihito, Kishi, Yukiko, Hamaki, Tamae, Yuji, Koichiro, Tanaka, Yuji, Komatsu, Tsunehiko, Kami, Masahiro
Format Journal Article
LanguageEnglish
Published United States 10.12.2008
Subjects
Antineoplastic Agents - adverse effects
Boronic Acids - adverse effects
Bortezomib
Clinical Trials as Topic
Cooperative Behavior
Drug Industry
Health Knowledge, Attitudes, Practice
Humans
Interdisciplinary Communication
Internet
Japan
Lung Diseases - chemically induced
Lung Diseases - prevention & control
Mass Media
Medical Staff
Multiple Myeloma - drug therapy
Newspapers as Topic
Patient Selection
Periodicals as Topic
Practice Guidelines as Topic
Pyrazines - adverse effects
Risk Assessment
Societies, Medical
Japan
Online AccessGet full text

Cover

More Information
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2008.20.3307